ProCE Banner Activity

Detecting EoE Across the Age Continuum: Expert Insights on the Impact of Diagnosis on Outcomes

Clinical Thought

Eosinophilic esophagitis is increasing in prevalence, but often goes unrecognized due to different prevailing symptoms for children and adults. Read this expert commentary to learn the impact of timely diagnosis and management on disease progression, clinical outcomes, and patient quality of life.

Released: September 18, 2024

Expiration: September 17, 2025

Share

Faculty

Seema S. Aceves

Seema S. Aceves, MD, PhD

Professor, Pediatrics and Medicine
MRD Endowed Chair in Pediatrics
Director, Eosinophilic Gastrointestinal Disorders Clinic
Division of Allergy Immunology
University of California, San Diego
Rady Children’s Hospital San Diego
San Diego, California

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Takeda Pharmaceuticals U.S.A., Inc.; and Regeneron Pharmaceuticals, Inc and Sanofi.

Regeneron Pharmaceuticals, Inc

Sanofi

Takeda Pharmaceuticals U.S.A., Inc.

Faculty Disclosure

Primary Author

Seema S. Aceves, MD, PhD

Professor, Pediatrics and Medicine
MRD Endowed Chair in Pediatrics
Director, Eosinophilic Gastrointestinal Disorders Clinic
Division of Allergy Immunology
University of California, San Diego
Rady Children’s Hospital San Diego
San Diego, California

Seema S. Aceves, MD, PhD: consultant/advisor/speaker: Sanofi/Regeneron, Sanofi; researcher (paid to institution): Bristol Myers Squibb; patent beneficiary: Takeda.